To improve the prognosis of HCC by diagnosing HCC at an early stage, a surveillance strategy using alpha-fetoprotein (AFP) and ultrasonography every six months is recommended for at-risk populations, including those with liver cirrhosis (LC) [4,5]. The gene discussed is AFP; the disease is hepatocellular carcinoma.